[ASND] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-May-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 44.95%
YoY- 25.82%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 5,414 10,515 20 18 28 280 434 438.70%
PBT -53,707 -32,066 -34,067 -22,876 -41,482 -34,361 -34,117 35.36%
Tax -70 -88 -100 -99 -107 -186 -240 -56.05%
NP -53,637 -31,978 -33,967 -22,777 -41,375 -34,175 -33,877 35.88%
Tax Rate - - - - - - - -
Total Cost 59,051 42,493 33,987 22,795 41,403 34,455 34,311 43.66%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -990.71 -304.12 -169,835.00 -126,538.89 -147,767.86 -12,205.36 -7,805.76 -74.77%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -1.24 -0.76 -0.81 -0.55 -1.07 -0.92 -1.04 12.45%
EPS Diluted -1.24 -0.74 -0.81 -0.55 -1.07 -0.88 -1.04 12.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.